MAIA Biotechnology, Inc. (MAIA)

1.33 -0.05 (-3.62%) USD  |  NYAM  |  Aug 28, 16:00
1.325 0.00 (0.00%) After-Hours: 20:00
More

MAIA Biotechnology Cash from Operations (Quarterly) : -6.750M for June 30, 2026

Cash from Operations (Quarterly) Chart

View Cash from Operations (Quarterly) for MAIA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Quarterly) Chart
Start Trial

Historical Cash from Operations (Quarterly) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -6.750M
March 31, 2026 -5.311M
December 31, 2025 -7.020M
September 30, 2025 -3.486M
June 30, 2025 -4.135M
March 31, 2025 -4.202M
December 31, 2024 -3.908M
September 30, 2024 -3.525M
June 30, 2024 -4.685M
March 31, 2024 -3.587M
December 31, 2023 -3.992M
Date Value
September 30, 2023 -3.157M
June 30, 2023 -2.561M
March 31, 2023 -3.361M
December 31, 2022 -2.509M
September 30, 2022 -4.319M
June 30, 2022 -2.282M
March 31, 2022 -2.546M
December 31, 2021 -1.607M
September 30, 2021 -1.311M
June 30, 2021 -0.951M
March 31, 2021 -0.2533M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Quarterly) Range, Past 5 Years

View Cash from Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Quarterly) Benchmarks

View Cash from Operations (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 813.00M
TG Therapeutics, Inc. 39.26M
ACADIA Pharmaceuticals, Inc. 100.78M
Alnylam Pharmaceuticals, Inc. 326.72M
Anika Therapeutics, Inc. -0.684M

Cash from Operations (Quarterly) Related Metrics

Cash from Financing (Quarterly) -0.065M
Free Cash Flow -22.57M
Free Cash Flow Per Share (Quarterly) -0.111
Free Cash Flow to Equity (Quarterly) -6.750M
Free Cash Flow to Firm (Quarterly) -6.750M
Free Cash Flow Yield -38.17%